NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Krivium Systems Achieves Estimated Valuation of ₹1,750 Crore

Krivium Systems, a Jaipur-based technology firm, has announced that its portfolio of proprietary technologies spanning artificial intelligence, clean energy infrastructure, consumer intelligence, and oncology research has achieved an estimated valuation of approximately ₹1,750 crore. This significant milestone comes without institutional venture capital backing, a testament to the company's innovative approach to intellectual-property development.

The company operates a range of proprietary platforms for industrial, enterprise, and research applications, positioning itself as an inventor-led enterprise. Its model focuses on intellectual-property development rather than conventional software services. Krivium's flagship offering, VGUS (VERITAS-GARUDA Unified Signal System), processes macroeconomic, regulatory, and institutional data, converting it into structured decision-support outputs. The platform has undergone extensive live operational testing, simulations, and stress analysis to serve institutional and market participants.

In the energy sector, Krivium's Hydrillite platform addresses hydrogen production and advanced energy storage, an area attracting considerable global investment as governments and private entities accelerate clean-energy programmes. A separate platform, Populah, is designed for consumer intelligence applications, providing near real-time analysis of behavioural trends and evolving buyer preferences across retail, branding, and demand forecasting functions.

Read also: Oshea Herbals Aims for Rs 650 Crore Revenue Amidst Expansion Efforts

The company has also developed FERROPTYX, an oncology research platform focused on treatment-resistant cancers. Krivium states that the platform encompasses multiple molecular candidates targeting biological pathways that are drawing growing attention within the international scientific community.

PlatformDescription
VGUSVERITAS-GARUDA Unified Signal System
HydrilliteHydrogen production and advanced energy storage
PopulahConsumer intelligence applications
FERROPTYXOncology research platform for treatment-resistant cancers

The company has indicated that its broader objective extends beyond individual platforms and characterises its approach as a repeatable innovation framework, a structured methodology for developing commercially relevant intellectual property across multiple and unrelated sectors.

Investor Takeaway

Investors should consider Krivium Systems as a potential long-term growth opportunity in the IT and technology sector.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.